Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2020-04-14 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于2019年度日常关联交易暨2020年度日常关联交易预计公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's related party transactions for the fiscal year 2019 and the forecast for 2020. It includes specific transaction amounts, counterparties, explanations of the necessity and fairness of the transactions, and independent directors' opinions. The document references compliance with Shenzhen Stock Exchange rules and includes board and supervisory committee meeting resolutions. It is not a full annual report or financial statement but a regulatory disclosure about related party transactions, which is a common type of regulatory filing. The document is longer than 5,000 characters and contains substantive content about the transactions, their impact, and governance approvals. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS) because it is a compliance disclosure about related party transactions and not a financial report or meeting material.
2020-04-14 Chinese
关于2019年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from a company regarding its 2019 annual profit distribution plan. It details the proposed dividend payout per share, references the board and supervisory committee's approval, and mentions that the plan is subject to shareholder approval at the annual general meeting. The document does not contain full financial statements or comprehensive financial performance data, but rather focuses on the dividend distribution proposal and related approvals. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders. The document length is relatively short (2229 characters), and it is not a full annual report or earnings release. Therefore, the appropriate classification is DIV with high confidence.
2020-04-14 Chinese
关于募集资金2019年度存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a special report on the deposit and use of raised funds for the year 2019 by 三诺生物传感股份有限公司. It details the amount of funds raised, their deposit, usage, management, and compliance with regulatory requirements. The content focuses specifically on the management and use of fundraising proceeds, including bank accounts, investment projects, and cash management. There is no indication that this is a full annual report, audit report, or earnings release. It is a detailed report on fundraising and capital usage, which aligns with the category of Capital/Financing Update (CAP). The document length is substantial (7592 characters), and it contains substantive financial data related to fundraising usage, not just an announcement or certification. Therefore, the best fitting classification is CAP.
2020-04-14 Chinese
2019年度募集资金年度存放与使用情况鉴证报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集资金年度存放与使用情况鉴证报告" which translates to "Annual Verification Report on the Storage and Use of Raised Funds" for the year 2019. It is issued by an accounting firm (ShineWing CPA) and addresses the shareholders regarding the management and use of funds raised through a non-public share issuance. The document contains detailed financial data about the amount raised, usage, storage, and management of the raised funds during the fiscal year 2019. It is a specialized report focusing on the verification of the use of capital raised, not a general annual report or earnings release. It is not a mere announcement or certification but contains substantive financial and management information about the raised funds. This type of document fits best under the category of Capital/Financing Update (CAP), as it provides updates on the company's fundraising and the use of those funds. The document length (9618 characters) and content confirm it is a full report, not just an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2020-04-14 Chinese
2019年12月31日内部控制鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Assurance Report" and an "Internal Control Self-Evaluation Report" for the fiscal year ending December 31, 2019, issued by SanNuo Biological Sensor Co., Ltd. It is prepared by a certified public accounting firm and addresses the effectiveness of internal controls related to financial reporting and other operational areas. The report includes detailed descriptions of internal control environment, risk assessment, control activities, information and communication, and internal supervision. It also discusses the identification and remediation of internal control deficiencies. The document is comprehensive, contains substantive evaluation and assurance content, and is not merely an announcement or certification. It is a standalone audit-related report focusing on internal control effectiveness, which aligns with the definition of an Audit Report / Information (AR). It is not an Annual Report (10-K) or Interim Report (IR) as it does not contain full financial statements or broad company activity coverage. It is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains the full report text and detailed analysis. Therefore, the appropriate classification is AR (Audit Report / Information).
2020-04-14 Chinese
2019年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the "2019 年度财务决算报告" which translates to "2019 Annual Financial Settlement Report." It contains detailed financial data for the full fiscal year 2019, including income statement, balance sheet, cash flow analysis, profitability analysis, and notes on accounting policies such as goodwill impairment. The document references an audit report issued by an accounting firm, indicating it is a formal annual financial report. The length of the document (9728 characters) and the presence of comprehensive financial statements and analysis confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K).
2020-04-14 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.